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Abstract

Previous research has demonstrated associations between stress and physical health
conditions, including skin disease. The stress cycle, including its associated hormonal responses
and stress behaviors, contributes to more severe skin disease symptoms. Psychological stress and
anxiety-disorder symptoms are known to be associated with skin disease severity; however,
research has yet to examine the relationships between stress-disorders and skin disease severity.
Therefore, stress disorders (e.g., posttraumatic stress disorder [PTSD]) are hypothesized to have
a similar relationship with skin disease severity, wherein greater severity of PTSD-related
symptoms would be positively associated with skin disease severity. Participants from Amazon’s
Mechanical Turk (N = 450) were screened for the presence of a dermatological condition in the
past year. Participants (n = 311) who endorsed skin disease symptoms completed online selfreport measures of skin disease characteristics and symptom severity, exposure to potentially
traumatic events, PTSD-related symptoms, perceived stress, and demographic information. The
sample was 68.2% white and 59.2% female, with a mean age of 33.9 years (SD = 11.0). Overall,
participants reported moderate perceived stress (M = 18.9, SD = 6.6), and subthreshold
symptoms of PTSD (M = 30.7, SD = 22). Bivariate correlations indicated significant positive
associations between perceived stress and PTSD symptoms (r = .644, p < .01), and PTSD
symptom clusters (r = .560-.677, p < .01). Skin disease severity was positively associated with
perceived stress (r = .257, p < .01), PTSD symptoms (r = .435, p < .01), and all PTSD symptom
clusters, with alterations in arousal and reactivity demonstrating the strongest relationship to skin
disease severity (r = .428, p < .01). Consistent with prior work among dermatological samples,
findings indicate skin disease severity was positively, significantly correlated with perceived
stress, PTSD symptoms, and PTSD symptom clusters. These results contribute to the existing
literature on stress and posttraumatic stress in dermatological populations. Future research
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directions may include additional dimensions of stress and stressful life events, as well as
clinician-rated evaluation of PTSD symptoms and skin conditions. Additionally, longitudinal
research examining the temporal relationship between PTSD symptoms, stress, and skin disease
is warranted.
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Introduction

Skin is the largest organ of the body, with a surface area of almost two square meters
(m2) for each human and compromising about 15% of the body’s total weight (Alexopoulos &
Chrousos, 2016). The skin serves as a physical barrier to protect an organism from the external
environment. It can be adversely affected by microorganisms, such as fungi, bacteria, viruses,
and potentially harmful substances, including harsh chemicals. Although the skin can be harmed
by these influences, exposure can prepare immune cells for responding to future harmful
microbes, and this process may result in skin diseases (Grice & Segre, 2011). There are
endogenous and exogenous variables that affect the relationship between the skin barrier and the
outer environment. Endogenous variables include uncontrollable factors, such as stress and
genetics that selectively allow certain microbes. Exogenous variables, by contrast, include
factors a person can control, including bathing and applying medications.
Reactions between immune cells and microorganisms cause various skin conditions, such
as psoriasis, acne vulgaris, eczema, and dermatitis. The 2010 Global Burden of Skin Disease
study estimated that there are 15 categories of skin diseases (Hay et al., 2010). Eight distinct skin
diseases are in the top fifty most prevalent diseases worldwide with three of those in the top ten
(Hay et al., 2010). Skin diseases are estimated to affect over 2.5 billion people around the world,
with approximately 1 out of 3 people affected worldwide and 1 out of 4 individuals
(approximately 84.5 million) in the United States (U.S.; Hay et al., 2010; Lim et al., 2017). In
2017, the Burden of Skin Disease Report for the U.S. classified nine additional categories of skin
diseases including acne, ulcers, urticaria, and pruritus (Lim et al., 2017). Certain skin conditions,
such as acne or dermatitis, can be nonfatal, whereas other skin conditions can be fatal, such as
melanoma or skin cancer. Skin cancer is the most common cancer worldwide (American Cancer
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Society [ACS], 2021), and nonfatal skin conditions are the fourth highest cause of nonfatal
disease burdens worldwide, making it the fourth most common cause of all human diseases
across the globe (Hay et al., 2010). Acne is the most prevalent skin condition in the U.S.,
affecting approximating 50 million people (Bickers et al., 2006). In the U.S., skin disease
treatment and prevention were estimated to cost over $75 billion in medical, preventative, and
drug costs in 2013 alone (Lim et al., 2017). Thus, skin disease is rampant, affecting the lives of
millions, and its associated treatment is costly not only to dermatological patients but also
healthcare systems. Further investigation into factors that cause skin diseases and affect disease
severity may assist in reducing the economic burden of future patient treatment. Some research
has been conducted to examine the role of internal factors on skin disease, such as stress (Bin
Saif et al., 2018; Chen & Lyga, 2014; Chiu et al., 2003), sleep quality (Chiu et al., 2003; Halioua
et al., 2021), and many other factors.
Skin disease symptom severity is idiosyncratic, and two of the many contributing factors
of increased severity symptoms are stress (Alexopoulos & Chrousos, 2016; Bin Saif et al., 2018;
Chen & Lyga, 2014; Chiu et al., 2003; Dixon et al., 2018; Kimyai-Asadi & Usman, 2001) and
mental health concerns, including anxiety disorders (Dixon et al., 2018; Dixon & Witcraft, 2020;
Guo et al., 2020). Dermatological patients have been found to report symptoms of both
depression and anxiety, with the latter being more prevalent among dermatology patients (Dixon
et al., 2016; Guo et al., 2020). Higher levels of anxiety are associated with more severe skin
disease symptomology (Basavarai et al., 2010; Dixon et al., 2016). Dermatology patients also
reported that their experiences with skin disease, including the associated symptoms and physical
presentation, were commonly associated with greater distress and diminished quality of life
(Urpe et al., 2005).
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A cyclical relationship appears to affect individuals in dermatological populations, such
that skin disease symptoms are associated with higher levels of stress and, in turn, higher levels
of stress from external sources are associated with lower quality of life and higher distress (Urpe
et al., 2005). The stress cycle itself involves biological and psychological components wherein
the hormones associated with the stress response are excreted according to the corresponding
phase of the cycle (Chen & Lyga, 2014; Reznick, 1989; Rom & Reznick, 2016), and these
hormones may, and often do, adversely affect the exhibited skin condition (Pondeljak &
Lugovic-Mihic, 2020). This secretion of hormones begins a series of biochemical processes
throughout the body in response to the initial stressor (e.g., the associated skin condition for
dermatology patients), and its response acts as a means for the body to adapt to the stress (Chen
& Lyga, 2014; Reznick, 1989; Rom & Reznick, 2016). Excess or even inadequate stress
responses may trigger negative physiological effects, including certain diseases or adverse health
conditions (Cohen et al., 2007). In essence, stress wrought on by the presence of a skin condition
may exacerbate the condition, thus causing more stress, and repeating into an endless cycle.
Multiple studies have found that greater stress is associated with worsened skin disease
symptoms and quality of life (Alexopoulos & Chrousos, 2016; Bin Saif et al., 2018; Chen &
Lyga, 2014; Chiu et al., 2003; Dixon et al., 2016; Dixon et al., 2018; Kimyai-Asadi & Usman,
2001). In dermatology samples, stress disorders and anxiety disorders are associated with lower
quality of life, including poor quality of sleep and more sleep disturbances (Singareddy et al.,
2003), more severe anxiety and depression symptoms (Urpe et al., 2005), increased social
impairment from skin disease (Dalgard et al., 2015; Halvorsen et al., 2011; Jowett & Ryan,
1985), more severe social avoidance (Singareddy et al., 2003), lower self-image (Urpe et al.,
2005), weakened immune system contributing to increased frequency of skin disease flare-ups
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particularly in patients with autoimmune skin conditions (Graham et al., 2006), and increased
avoidance of beneficial physical health behaviors such as eating healthy and exercising
(Horenstein et al., 2018). With growing evidence to suggest a relationship between stress and
skin disease, recent research has begun to clarify the relationships between specific types of
stress and skin disease severity.
Although psychological stress is key in many mental health disorders, posttraumatic
stress disorder (PTSD) and acute stress disorder (ASD) are two commonly experienced disorders
classified under Trauma- and Stress-related Disorders. Stress disorders, as defined by the DSM-5
(DSM-5; American Psychiatric Association [APA], 2013), are characterized by specific
symptoms (e.g., alterations in arousal and reactivity such as problems with concentration) and
stress in an individual following exposure to a potentially traumatic or stressful event (APA,
2013). Traumatic experiences, which may potentially elicit symptoms that later develop into
ASD or PTSD, are outlined by the DSM-5 and include exposure to actual or threatened death,
injury, or sexual violence by either directly experiencing the event, witnessing the event occur,
learning of the event occurring to someone close, or experiencing repeated or extreme exposure
to aversive details of a potentially traumatic event (PTE; APA, 2013). PTSD and ASD are both
trauma-related disorders and while their symptom diagnostic criteria overlap, their time frame
differs. ASD entails experiencing DSM-5 criteria for 3 days to 1 month following a PTE,
whereas experiencing DSM-5 criteria for over 1 month qualifies as PTSD (APA, 2013).
Characteristic symptoms of PTSD are outlined in the DSM-5 and divided into four
subscales of the PTSD Checklist for DSM-5 (PCL-5; Sveen et al., 2016), which is a measure
commonly used in research and clinical settings to assess symptomology of PTSD-related
symptoms and to provide a provisional PTSD diagnosis (APA, 2013; Sveen et al., 2016). Such
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symptoms that characterize presentation of a trauma-related stress-disorder such as PTSD
include fear-based re-experiencing or intrusive physiological reactions or thoughts (Cluster B;
intrusion; e.g., nightmares of the traumatic event), avoiding stimuli potentially associated with
the traumatic event (Cluster C; e.g., avoiding the location where the event occurred), negative
changes in mood and cognitive ability (Cluster D; e.g., difficulty remembering details of the
traumatic event), and changes in arousal, behavior, and emotional or physiological reactivity
(Cluster E; e.g., irritable behavior or unexpected outbursts of anger; Sveen et al., 2016).
Exposure to PTEs is common, with approximately 89.7% of individuals in the U.S.
experiencing these events at some point in their life (Kilpatrick et al., 2014). The most common
PTEs, using DSM-5 criterion, are physical or sexual assault (53.1%), death of a loved one
(51.8%), natural disaster (50.5%), and accident or fire (48.3%) (Kilpatrick et al., 2014). A recent
study estimated that the overall lifetime prevalence of PTSD among civilians in the U.S. is
approximately 6%, with higher prevalence rates for women than men and much higher rates for
people of American Indian or Alaska Native descent (23%) than people of any other race
(Schein, et. al., 2021). A 2005 study estimated PTSD prevalence for the U.S. adult population to
be around 6.8%, showing that the prevalence of PTSD has remained mostly unchanged (Kessler
et al.). Prevalence of PTSD appears to be the greatest in veterans and individuals who have been
involved with the military, with the highest prevalence among Vietnam veterans (Kang et al.,
2003; Kulka et al., 1990).
PTSD can be a debilitating disorder, impacting each area of a person’s life from
physiological reactions (e.g., sweating), cognitive changes (e.g., intrusive, disturbing thoughts),
and social changes (e.g., one’s ability to interact with others; McFarlane & Bookless, 2001).
Previous studies have evaluated the relationship between PTSD and quality of life,
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demonstrating that a negative association exists between the two. That is, greater severity of
PTSD correlates with a worse overall quality of life (Cohen et al., 2009; Sareen, 2018). PTSD
and its associated symptoms are intrusive, bothersome, and disruptive as PTSD is associated
with increased risk of other health problems such as depression and anxiety, drug or alcohol use,
and autoimmune or endocrine diseases (Hoopsick et al., 2019; Sareen, 2018). PTSD severity has
been observed to be positively correlated with chronic stress and abnormally prolonged and
elevated stress hormone levels (Pitman et al., 2012; Sherin & Nemeroff, 2011). In previous
studies, when exposed to reminders of the previously experienced traumatic event, individuals
with PTSD exhibited much higher cortisol (i.e., stress hormone) levels than those without PTSD
who previously experienced a similar traumatic event (Elzinga et al., 2003).
The relationships between trauma-related symptoms and the stress cycle continue to be
investigated (Videlock et al., 2008); however, PTSD-related symptoms have been observed to
overlap with chronic stress, which can lead to inability to demonstrate adequate fear or stress
responses or an inability to control fear or stress (Maeng & Milad, 2017). This can exacerbate
PTSD symptoms, suggesting another potential ongoing stress cycle in individuals with PTSD
symptoms (Maeng & Milad, 2017). Because of the primary stress cycle affecting physical
disease and the possibility of another stress cycle between PTSD symptoms and chronic fear or
stress, this secondary stress cycle may further exacerbate skin conditions among dermatology
patients who endorse PTSD-related symptoms. Therefore, PTSD symptomology may be strongly
associated with skin disease severity, and dermatological patients with PTSD may experience
more severe skin disease symptoms, particularly due to the additional stress and associated stress
hormones (e.g., cortisol, which impacts the immune system) resulting from the traumatic event.
However, there are difficulties in diagnosing and treating both PTSD and skin disease.
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Estimated prevalence of PTSD among dermatological patients ranges from less than 5%
to 76%, depending on the skin condition (Gupta et al., 2017). In dermatological patients with
diagnosed PTSD, skin disease flare-ups are often associated with the physiological reactions
related to trauma symptoms, such as profuse sweating caused by autonomic hyperarousal at the
reminder of the initial traumatic event (Gupta et al., 2005). Thus, the behavioral and
physiological effects of PTSD on dermatological patients can negatively affect skin disease
symptoms long after the traumatic event occurs (Gupta et al., 2005). Stress is negatively
associated with quality of life and positively associated with skin disease severity, such as flareups of the skin disease (Bin Saif et al., 2018; Chen & Lyga, 2014; Chiu et al., 2003; Graham et
al., 2006; Gupta et al., 2005; Gupta et al., 2017). These relationships have been observed across
various age groups (Abadie et al., 1994; Hafsia et al., 2019), cultures (Gupta et al., 2005; Gupta
et al., 2017), races (Gupta et al., 2005; Gupta et al., 2017), genders (Koblenzer, 1997), and even
causes of stress (Besiroglu et al., 2009; Kussainova et al., 2020). Skin health and skin disease
severity can vary among individuals diagnosed with a stress-disorder (Friedman et al., 2011).
While many studies have examined the relationships between stress and skin disease symptom
severity, demonstrating that skin disease worsens with greater stress (Bin Saif et al., 2018; Chen
& Lyga, 2014; Chiu et al., 2003), very few have studied these relationships with specific types of
PTEs.
Evidence suggests that stress-disorder-related symptoms may have a significant impact
on skin disease severity by impairing functioning, mental wellbeing, and quality of life (Cohen et
al., 2009; Gupta et al., 2005; Gupta et al., 2017; Hoopsick et al., 2019; Maeng & Milad, 2017;
Sareen, 2018). However, no known studies have examined the relationship between PTSD and
skin disease, specifically the relationship between the number or types of PTEs (e.g., sexual
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assault, natural disaster, etc.), perceived stress, specific stress-disorder-related symptoms, and
skin diseases. Due to the prevalence and psychological toll of PTSD, stress, and physical illness,
further research and understanding of this relationship will aid in better understanding PTSD,
skin disease, and how skin disease is affected by exposure to PTEs. Increased understanding of
this relationship additionally will promote awareness of this relationship, especially among the
medical community.
With the current gaps in the literature regarding trauma-disorder-related symptoms and
skin disease symptom severity, this study will enhance our understanding of how individuals
with skin disease experience PTEs and PTSD symptoms. This study will also enhance our
understanding of the relationship between stress, PTSD symptoms, and skin disease symptom
severity. The following aims and hypotheses were investigated:
1. First, this study examined perceived stress levels, occurrence of potentially traumatic
events, PTSD symptoms, and skin disease symptom severity among individuals with skin
disease symptoms.
2. Second, this study examined skin disease symptom severity in relation to perceived stress
and PTSD symptoms.
a. Hypothesis 1: Greater severity of PTSD symptoms and greater perceived stress
would be associated with more severe skin disease presentation.
3. Third, specific PTSD clusters of symptoms (e.g., intrusion) were evaluated in relation to
skin symptom severity.
a. Hypothesis 2: The cluster relating to arousal and reactivity will be positively
associated with skin disease symptom severity.
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Methods

Participants
Participants (N = 450) were recruited through TurkPrime from Amazon’s online
Mechanical Turk (MTurk) service. MTurk has been evaluated to be a reliable and efficient
source for generalized, diverse samples and is cost-efficient (Burhmester et al., 2011; Litman et
al., 2017). Participants answered a series of self-report questionnaires about skin condition
symptomology, stress, and mental health, including PTSD-related symptom severity. The sample
was limited to individuals living in the United States, which was determined by IP address.
Participants who were 18 years of age or older and reported experiencing dermatological or skin
disease symptoms within the past 12 months were included in the study. Those who were under
18 and those who did not self-report any skin disease symptoms within the past year were
excluded from the study.
Participants were compensated $0.10 upon completion of a brief screening questionnaire.
Those who were determined to be eligible by the initial screener assessing skin-related
symptoms were invited to take part in the full study. Participants were compensated up to $3.50
upon completion of the study’s questionnaire packet, which took approximately 30 minutes to
complete. This compensation is in accordance with and in proportion to the compensation
provided by other crowd sourcing tasks of similar duration offered through Amazon.com's
Mechanical Turk and TurkPrime (Buhrmester et al., 2011; Paolacci et al., 2010). All study
protocols and procedures were approved by the University of Mississippi’s Institutional Review
Board (IRB).
Measures
Demographics
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Demographic information was obtained through a self-report questionnaire developed by
the researchers. Participants answered questions about gender, racial/ethnic background,
relationship status, education, residential information, religion, and employment.
Skin Disease Characteristics
Physical health and skin condition information was obtained through self-report
questionnaires which asked participants about their dermatological symptoms throughout the
past year. Additional dermatological information included diagnoses, factors that affected
symptom onset, severity, and physical presentation of the skin condition. See Appendix A.
Skin Symptom Severity
Skin symptom severity was self-reported on a 0 to 10 scale, with 0 = normal or no
symptoms and 10 = very severe symptoms. This single item measuring skin symptom severity
asks how the participant would rate their skin disease severity on a scale 0-10 and has been used
in prior work to examine skin symptom severity among dermatology patients and online samples
of adults with skin disease (Böhm et al., 2014; Dixon et al., 2018; Gupta & Gupta, 1995;
Montogomery et al., 2016; Salman et al., 2016).
Potentially Traumatic Events
Experience of potentially traumatic events (PTEs) was assessed with the Life Events
Checklist for DSM-5 (LEC-5; Gray et al., 2004; Weathers, Blake, et al., 2013). The LEC-5 is a
17-item measure that lists a variety of potentially traumatic events outlined by DSM-5 criteria
(e.g., natural disaster), and the response options for experiencing the event include direct,
indirect, occupational, and no experience. The measure is scored using a 6-point nominal scale.
This measure does not produce a composite or total score. In order to better analyze the
participant data, the options “witnessed it” and “learned about it” were dichotomized to form one
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response and are hereby referred to as “indirectly happened to me,” whereas the response options
“not sure” and “doesn’t apply” were also dichotomized under one response. See Appendix B.
PTSD Symptoms
PTSD symptom severity was measured by the PTSD Checklist for DSM-5 (PCL-5). The
PCL-5 is a 20-item questionnaire designed to measure severity of distress and frequency of
posttraumatic stress symptom severity, such as repeated, disturbing dreams of the stressful
experience and difficulty concentrating, in the past month in response to a PTE (Blevins et al.,
2015; Sveen et al., 2016; Weathers, Litz, et. al., 2013). Participants indicate to which extent they
agree with each statement (e.g., being bothered by “repeated, disturbing dreams of the traumatic
event,” “feeling jumpy or easily startled,” etc.) on a 5-point Likert-type scale, ranging from 0
(Not at all) to 4 (Extremely) with higher scores corresponding to more severe PTSD
symptomology. The PCL-5 has four subscales, including five items assessing intrusion
symptoms (e.g., reliving memories of the event), two items on avoidance (e.g., avoiding physical
and introspective reminders of the traumatic event), seven items on negative alterations in
cognitions and mood (e.g., experiencing issues remembering the traumatic event or experiencing
more negative emotions towards oneself or others), and six items on alterations in arousal and
reactivity (e.g., feeling on high-alert or behaving irrationally; Sveen et al., 2016). The items are
summed and yield a total score ranging from 0 to 80. A cutoff score of 33 is recommended to
predict a provisional DSM-5 PTSD diagnosis (Bovin et al., 2016) and is indicative of probable
PTSD (Weathers, Litz, et al., 2013). See Appendix C.
Stress Symptoms
The PSS is a 10-item questionnaire that assesses ability to cope with perceived stress
(Cohen et al., 1994). Participants rate how often they experienced stress and their ability to cope
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with stress over the past month (e.g., how often they have been “upset because of something that
happened unexpectedly” and “how often [they] have felt stressed or nervous”) using a 5-point
Likert-type scale, ranging from 0 (Never) to 4 (Very often). Items are summed and higher scores
are indicative of greater levels of perceived stress. Scores can range from 0 to 40, wherein 0-13
is considered low stress, 14-26 is moderate stress, and 27-40 is high stress (Cohen et al., 1994).
Prior work has found that higher scores have been associated with higher cortisol levels,
suppressed immune function, greater inflammation, and higher susceptibility to infection (Cohen
& Janicki-Deverts, 2012). Each of the PSS-10 subscales was also significantly correlated with
anxiety and depression (Maroufizadeh et al., 2018). See Appendix D.
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Results

Participant Characteristics
In the final sample of participants (N = 311), most participants were women (59.2%). The
average age of participants in the study was 33.9 years (SD = 11.0). Additionally, most
participants were white (68.2%). See Table 1 for a summary of demographic characteristics.
With regard to dermatological characteristics, 24 skin conditions were reported. The most
prevalent skin conditions were eczema (35%), acne (27.3%), rosacea (17.4%), facial dermatitis
(15.8%), psoriasis (14.8%), hyperhidrosis (14.5%), and fungal infections (14.4%). Over half
(67.2%) of the sample reported itching as a current skin disease symptom. Other commonly
experienced current symptoms included dryness or peeling (60.5%), redness (59.8%), pain
(39.9%), and color changes (39.2%). Almost half (45.3%) of the sample reported that the
severity of skin condition was between moderately severe and very severe, and 30.8% of
participants reported their skin disease severity to be between normal and moderate. More
participants reported that their skin condition has worsened in the past year (31.5%) than has
improved (23.5%). However, more participants reported that their skin condition has remained
stable in the past year (45%). The most commonly reported area of current skin disease
presentation was the face (59.2%), but the most commonly reported area for skin disease
presentation in the past year was the torso or back (40.5%). The aforementioned data and further
self-report data on the sample’s skin disease characteristics is detailed in Table 2.
The majority of participants reported directly experiencing (77.5%) and indirectly
experiencing (i.e., witnessing or learning about an event; 85.9%) at least one PTE. The most
commonly endorsed directly experienced PTE was a transportation accident, such a motor
vehicle accident (39.5%). Similarly, the most commonly endorsed indirectly experienced PTEs
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were a transportation accident (47.6%) and life-threatening illness or injury (46.6%). See Table
3.
Descriptive Statistics and Bivariate Correlations
The mean PSS total score was 18.9 (SD = 6.6). The mean PCL-5 total score was 30.7 (SD
= 22.0). For the PCL-5, 47.3% of the participants met the 33-score cutoff recommended for a
provisional PTSD diagnosis (Bovin et al., 2016; Weathers, Litz, et al., 2013). Additional means
and standard deviations of the PSS, PCL-5, and PCL-5 clusters are reported in Table 4.
To test the hypothesis that higher PTSD symptom severity and higher stress would be
associated with greater skin disease severity, bivariate correlational analysis were conducted with
PTSD symptom severity (i.e., PCL-5) and perceived stress (i.e., PSS) with skin disease severity
which was measured using the single item for skin disease severity. Consistent with Hypothesis
1, more severe skin disease presentation was moderately correlated with higher total scores on
the PCL-5 (r = 0.435, p < .01) and weakly correlated with higher total scores on the PSS (r =
0.257, p < .01). Thus, results indicated that higher PTSD symptom severity and higher perceived
stress were associated with more severe skin disease presentation.
In order to test the hypothesis that the PCL-5 cluster related to alterations in arousal and
reactivity would have the strongest association with skin disease severity, scores from each PCL5 cluster were analyzed against skin disease severity via bivariate correlational analysis. Results
suggest that, consistent with hypothesis 2, Cluster E (i.e., the cluster relating to arousal and
reactivity) was observed to be moderately correlated to more severe skin disease presentation (r
= 0.428, p < .01). Out of the four PCL-5 clusters, Cluster E was the most strongly correlated to
skin disease severity than any other cluster. Skin disease symptom severity was observed to have
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a moderate correlation between Cluster B – intrusion (r = .420, p < .01), Cluster C – avoidance (r
= .389, p < .01), and Cluster D – alterations in arousal and reactivity (r = .402, p < .01).
By demonstrating strong positive correlations between the PSS total and PCL total,
perceived stress and PTSD-related symptom severity were observed to be significantly positively
associated (r = .644, p < .01). Perceived stress (i.e., PSS total) and PTSD-related symptoms of
negative alterations in cognitions and mood (Cluster D) were observed to have a significantly
positive relationship as well (r = .677, p < .01). By exhibiting moderate positive correlations,
perceived stress was also observed to have a significantly positive relationship between intrusion
symptoms (i.e., Cluster B; r = .560, p < .01), avoidance symptoms (Cluster C; r = .592, p < .01),
and alterations in arousal and reactivity (Cluster E; r = .582, p < .01).
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Discussion

The present study sought to examine the associations between perceived stress, severity
of PTSD-related symptoms, and skin disease severity. The primary aim of this study was to
examine perceived stress levels, occurrence of PTEs, PTSD symptoms, and skin disease
symptom severity among individuals with skin conditions. Despite previous research
demonstrating a positive association between stress and skin disease severity (Alexopoulos &
Chrousos, 2016; Chiu et al., 2003; Koo et al., 2001; Pondeljak & Lugovic-Mihic, 2020; Reich et
al., 2010), there is very little research on the relationships between PTSD symptoms and skin
disease in dermatology. Consequently, the present study added to the understanding of the
relationship between PTSD, stress, and skin disease severity. The results supported both
hypotheses that greater PTSD severity and greater perceived stress were associated with more
severe skin disease symptoms and that the cluster of symptoms related to arousal and reactivity
(i.e., the PCL-5 Cluster E) was positively associated with skin disease symptom severity. These
results suggest that increased levels of hyperarousal and reactivity, such as sweating, may
negatively influence severity of skin disease symptoms.
Our sample characteristics were similar to that of the U.S. in terms of race, sex, marital
status, employment status, education, and social class. In the U.S., the population is
approximately 51% female (U.S. Census Bureau, 2019), 57.8% white (U.S. Census Bureau,
2021a; U.S. Census Bureau, 2021c), 46% middle class (Beeghley, 2004), 40% working class
(Beeghley, 2004), 50% married (U.S. Census Bureau, 2021a). The current study’s sample was
59.2% female, 68.2% white, 60.5% middle class, 31.5% working class, and 44.7% married.
In the current sample, the most prevalent skin diseases were eczema (35%), acne
(27.3%), and rosacea (17.4%). In the U.S., the most prevalent skin conditions are noncancerous
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skin growths (7.81%); cutaneous infections (5.75%); viral and fungal diseases (5.75%), which
includes herpes and dermatomycosis; contact dermatitis (4.17%); hair and nail disorders
(2.55%), which includes alopecia; and acne (1.63%) (Lim et al., 2017). Thus, the prevalence of
skin diseases in the study did not align with the most prevalent skin diseases of the U.S.
population. This result is likely because the most commonly reported skin diseases for the
present study were chronic, primarily conditions that are difficult to treat. In contrast, for the
U.S., the most common skin conditions are more short-lived and can be more easily treated (e.g.,
infections treated with antibiotics). In the study on skin disease prevalence in the U.S. by Lim et
al., the most prevalent skin conditions were not similar to that of the present study; however, this
may be due to the different data collection method. Data in the study by Lim and colleagues were
collected by examining health insurance claims about skin diseases being currently experienced
by the patients. The present study used a self-report method wherein participants record their
skin condition which was not able to be verified by health professionals. The contrast in the most
prevalent skin conditions in both studies may be due to this difference in data collection and
verifiability by a physician.
The most commonly reported skin disease severity was between moderately severe and
very severe (n = 141, 45.3%). This is not consistent with U.S. statistics on the majority of people
who endorse skin disease, in which less than 10% of people with skin disease report severe
symptoms (Lello et al., 1995). Because of the severity of their skin condition, individuals with
more severe skin disease symptoms may be more likely to participate in research and other
endeavors to better understand skin conditions and how they are affected by other variables.
Of the general U.S. population, 89.7% reported exposure to at least one potentially
traumatic event (Kilpatrick et al., 2014), compared to the current sample of which 96.5%

PTSD & SKIN DISEASE SEVERITY

18

reported exposure to at least one PTE. Participants in the current sample reported between zero
and seventeen PTEs, with most individuals endorsing approximately three events. The most
commonly endorsed event in this sample was motor vehicle accidents, with 39.5% reported
directly experiencing and 47.6% reported indirectly experiencing such an event. Meanwhile, the
prevalence of transportation accidents (reported as PTEs) in the U.S. is between 15.5% (de Vries
& Olff, 2009) and 43.2% (Alim et al., 2006; Overstreet et al., 2016). The results of the current
study on PTEs are not consistent with prior research as the most commonly reported PTEs in the
U.S. are physical or sexual assault (53.1%), death of a loved one (51.8%), and natural disaster
(50.5%; Kilpatrick et al., 2013). Transportation accidents being the most prevalent PTE in this
study may be due to the increased need for healthcare patients to travel in order to receive care
for their physical health condition and of their psychological disorder. As they have an increased
need for motor vehicle travel, dermatological patients may have a higher chance of experiencing
a transportation accident as opposed to the general population.
Clinically significant levels of perceived stress were observed within the current study’s
sample of individuals who reported PTEs. In previous literature, perceived stress has been found
to be higher in conjunction with more severe PTSD symptoms following a PTE, such as
receiving a cancer diagnosis (Zhang et al., 2020), natural disasters (Leon et al., 2007; PedrozoPupo et al., 2020), and sexual violence (Catabay et al., 2019). The relationship between PTSD
severity and perceived stress, wherein increased stress is associated with increased PTSD
severity, has also been observed in samples with chronic health conditions (Chung et al., 2010).
Thus, the current study’s results are consistent with previous research suggesting that higher
levels of stress are associated with greater trauma symptom severity in individuals with physical
health concerns.
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In the current study’s sample, 47.3% of participants met the 33-score cutoff
recommended to predict DSM-5 PTSD diagnosis (Bovin et al., 2016; Weathers, Litz, et al.,
2013). This is higher than findings in other medical samples, specifically populations with
cardiovascular issues (4-24%, Tulloch et al., 2015), chronic pain (9.5%; Siqveland et al., 2017),
gastrointestinal issues (36%; Glynn et al., 2021), autoimmune diseases (16%; Li et al., 2019),
and diabetes (8%; Trief et al., 2006). Compared to the current study’s sample wherein the
average PCL-5 score was 30.7, PTSD severity is higher in veteran populations such that the
average PCL-5 score is between 35 and 43 (Bovin et al., 2016). Thus, the current study’s results
are inconsistent with previous research, suggesting that, compared to other populations with
health conditions, individuals with skin disease may experience more severe perceived stress and
PTSD-related symptoms. This may be due to the physical presentation of skin disease affecting a
person’s individual stress levels and social activity, whereas other health conditions, such as
gastrointestinal issues, are not characterized by visible physical presentation. The physical
presentation associated with skin disease may cause heightened stress, particularly in regard to
social activity and social avoidance. Supporting this point, results indicated a significant positive
correlation between perceived stress and the cluster of trauma-related symptoms of avoidance,
which is most similarly related to social activity. As indicated by the significant positive
relationship, a relationship exists between personal stress and social avoidance.
The second aim of the study was to examine skin disease symptom severity in relation to
perceived stress and PSTD symptoms. Consistent with the first hypothesis, greater PTSD
severity was observed to be associated with more severe skin disease. These results are similar to
previous studies involving other health condition populations and contribute to findings
suggesting that more severe post-traumatic stress occurs alongside greater perceived stress and
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worsened physical health concerns (Bin Saif et al., 2018; Chen & Lyga, 2014; Chung et al.,
2010). Research has suggested that a relationship exists between PTSD and physical health and
that this relationship be examined further (Glynn et al., 2021; Kang et al., 2003; Li et al., 2019;
Trief et al., 2006; Tulloch et al., 2014; Zhang et al., 2021). As the current study’s findings were
consistent with previous literature, this suggests that greater severity of health conditions,
including skin diseases, may be affected by the severity of post-traumatic stress and the severity
of personal stress. Further research into this relationship may allow for a better understanding,
including in other health populations where this relationship may be present. Although
directionality cannot be inferred from the current results, these findings additionally suggest a
future research direction examining the impact of stress associated with trauma on the stress
cycle, which may trigger adverse physiological effects (e.g., exacerbation of skin disease
symptoms) as a biological stress response (Cohen et al., 2007).
Higher levels of stress were also significantly associated with greater skin disease
severity. This further supports the stress cycle theory, specifically suggesting that greater skin
disease severity is associated with greater stress, which also influences skin disease severity.
Further, the cyclical nature of this pattern of results may extend to include trauma symptoms,
where greater trauma-related symptoms, such as social avoidance, increase personal stress which
then impacts skin disease severity. Because stress may likely accompany PTSD symptoms, stress
may further affect PTSD symptom severity, such that greater stress may be associated with
greater trauma-related symptom severity. This relationship and partnered existence of PTSD
symptomology and stress may adversely and exponentially impact the reported skin condition.
This finding supports the stress cycle theory and the potentiality of this cyclical relationship
expanding beyond personal stress and including stress disorders. The intersectionality of PTSD
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and stress in the stress cycle may explain the unexpectedly high PCL-5 scores (i.e., high PTSD
symptom severity) of the participants in the study, suggesting that higher stress may impact the
severity of PTSD symptoms and skin disease, which would cyclically affect stress severity. This
high level of symptoms may also be due to the stress hormones, such as cortisol, being critical in
the severity of PTSD and personal stress, and this may further explain the relationship with skin
disease severity, as higher levels of cortisol and other hormones are associated with weakened
immune systems and more severe physical health (Cohen et al., 2007; Pondeljak & LugovicMihic, 2020).
The third aim of the study was to examine the relationships between specific clusters of
post-traumatic stress symptoms (e.g., intrusion) and skin symptom severity. Consistent with the
second hypothesis, the alterations in arousal and reactivity trauma-related symptom cluster (i.e.,
Cluster E of the PCL-5) had a moderate relationship with skin disease symptom severity.
Additionally, each of the post-traumatic stress symptom clusters was also positively related to
skin disease severity, meaning that each PTSD-related symptom increasing in severity may
influence the severity of the skin disease. Despite the mean score of the negative alterations in
cognitions and mood cluster being higher, negative alterations in arousal and reactivity was more
strongly related to skin disease severity. These results suggest that even though other PTSDrelated symptoms in an individual may be more severe, symptoms related to arousal and
reactivity may have more of an influence on the severity of the person’s skin disease. Given the
cross-sectional nature of the study, it is not clear temporally which occurred first in the study’s
population: the skin disease severity or the post-traumatic stress symptoms. What these results
suggest, however, is that individuals endorsing skin disease symptoms may experience more
severe skin disease, post-traumatic stress, and hyperarousal PTSD-related symptoms, which may
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be associated with worsened skin disease symptoms. Previous research has suggested that
autonomic hyperarousal and reactivity related to one’s PTSD may influence skin disease severity
(Gupta et al., 2005); however, relationships between specific PTSD-related symptoms and skin
disease severity were previously unknown. This study demonstrates that each symptom related to
PTSD likely influences skin disease severity and suggests the possibility of PTSD symptoms
influencing other health conditions as well.
All associations between the variables listed in Table 4 were significant; however, some
relationships were notably weaker than anticipated, particularly the relationship between PSS
total (i.e., perceived stress) and skin disease severity. This suggests that PTSD severity has a
stronger relationship with skin disease severity than perceived stress, which is inconsistent with
previous studies that demonstrate stress and skin disease severity tend to be significantly
associated, in that greater stress is often associated with more severe skin disease (Bin Saif et al.,
2018; Chen & Lyga, 2014; Chiu et al., 2003). Significantly positive relationships were observed
between trauma-related hyperarousal symptoms and skin disease severity, between each cluster
of the trauma-related symptoms, and between severity of perceived stress and severity of PTSDrelated symptoms. The significant positive associations between the PCL-5 clusters were
expected and suggest that PTSD symptoms may likely occur together. This result also suggests
that single PTSD-related symptoms may not appear alone in individuals and may likely occur
alongside other PTSD-related symptoms (e.g., avoiding a physical reminder of the traumatic
event occurring alongside angry outbursts).
These results support previous literature that examines PTSD, perceived stress, and
physical health. While the relationship between stress and skin disease severity has previously
been demonstrated to have a significant positive relationship (Alexopoulos & Chrousos, 2016;
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Catabay et al., 2019; Chiu et al., 2003; Koo & Lebwhol, 2001; Pondeljak & Lugović-Mihić,
2020; Reigh et al., 2010), the relationship between PTSD-related symptoms and skin disease
severity has not been previously examined in empirical studies (e.g., Gupta et al., 2017; Gupta et
al., 2005).
The current study’s results were similar to medical populations, wherein populations with
health conditions were observed to have greater stress or greater PTSD symptom severity with
greater severity of their health conditions; similarly, this study’s results demonstrated that there
may also be a significant relationship between stress and skin disease severity (Alexopoulos &
Chrousos, 2016; Catabay et al., 2019; Chiu et al., 2003; Koo & Lebwhol, 2001; Pondeljak &
Lugović-Mihić, 2020; Reigh et al., 2010). However, this study also did not account for chronic
stress, everyday stress, other types of stress, and other factors that may impact personal stress, all
of which may differently affect an individual’s skin disease severity, and which may have
produced different results.
Additional limitations of the study include not being able to verify which skin conditions
are self-reported and endorsed by a medical professional, not being able to have medical
diagnoses to support the self-reported skin conditions, and not having a broader and more diverse
sample. The current study relied on self-report measures of psychological and dermatological
assessments. Physical exams, verification by a medical professional, or another form of a formal
diagnosis to support the self-reported information would provide more accurate and verified
data. PTSD symptoms were also self-reported by participants, and high participant scores of the
PCL-5 were not able to be verified by a mental health professional. In addition, other potentially
traumatic events that participants may have experienced were not listed as options to self-report.

PTSD & SKIN DISEASE SEVERITY

24

Furthermore, some participants may view some events as traumatic that others may not view as
traumatic.
A further limitation of the study resides in the impossibility of researchers to determine
which of the following appeared first within the participants of the sample: the skin condition,
stress, or PTSD. The researchers also could not determine causes of participants’ stress,
participant hygiene practices, participant skin types that may affect their skin disease severity
(e.g., excessively oily skin), and what other biological conditions affect their skin disease. Due to
the limited amount of literature on this topic and these relationships, conclusions about
generalizability may be limited in scope.
For future directions, clinician-administered measures are suggested to be used in order
to produce more reliable results. Clinician-confirmed diagnoses from participants who self-report
skin conditions may reduce the limitations in future studies. The current study’s findings indicate
the potential benefit of dermatologists regularly assessing their dermatology patients’ mental
health, and future researchers in the field of dermatology may benefit from including stress- and
PTSD-related measures among future samples. Furthermore, controlled longitudinal studies are
needed to better understand the relationship between the stress cycle and skin and to evaluate
participants’ mental health, stress, PTSD-related symptoms, and other variables following a
traumatic event. This study and the relationships examined suggest further research is needed to
understand the relationship between mental health and physical health. Using this information,
dermatologists and other physicians may produce the appropriate referrals to the correct
psychological services in order to treat the psychological condition potentially affecting the
patient’s physical health. This may allow more adequate treatment for not only the individual’s
mental health but also for their physical health condition as well. Further acknowledgment,
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research, and education of the relationship between physical and psychological conditions,
particularly in dermatology, would allow for the provision of psychoeducational content. For this
to occur, future research needs to be conducted to better understand the stress cycle and its
relationship with physical health.
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Table 1 Sociodemographic Information
Characteristics
Age
18-35
36-55
56-99
Sex
Female
Male
Race/Ethnicity
White
African American
Asian
Hispanic, Latinx, or Spanish origin
Native American
Middle Eastern
Native Hawaiian/Other Pacific Islander
Other/prefer not to answer
Marital status
Married
Living with a partner/partners
Single
In a relationship but living apart
Education
Bachelor’s degree
Some college/vocational training
Master’s degree or higher
Associates degree
High school diploma or equivalent
Some post undergraduate work
Occupation status
Employed full-time
Employed part-time
Unemployed
Other
Retired
Self-identified social class Middle class
Working class
Poor
Affluent
Sexual Orientation
Straight
Bisexual
Gay/Lesbian
Other

39

n (%)
203 (65.3)
88 (28.3)
20 (6.4)
184 (59.2)
127 (40.8)
212 (68.2)
46 (14.8)
37 (11.9)
19 (6.1)
16 (5.1)
3 (1.0)
3 (1.0)
3 (1.0)
139 (44.7)
71 (22.8)
61 (19.6)
40 (12.9)
136 (43.7)
73 (23.5)
52 (16.7)
23 (7.4)
19 (6.1)
8 (2.6)
168 (54.0)
87 (28.0)
43 (13.8)
7 (2.3)
6 (1.9)
188 (60.5)
98 (31.5)
16 (5.1)
9 (2.9)
225 (72.3)
69 (22.2)
14 (4.5)
3 (1.0)

PTSD & SKIN DISEASE SEVERITY
Table 2 Skin Disease Information
Characteristics
Skin condition(s)
Eczema
Acne
Rosacea
Facial dermatitis
Psoriasis
Other conditions not listed in the measure
Other conditions listed in the measure
Current skin disease symptoms Itching
Dryness/peeling
Redness
Pain
Color changes
Rash/hives
Outbreak
Burning/stinging
Sores
Bleeding
Sweating
Other
Severity of skin condition
Between moderately severe and very severe
Between normal and moderate
Moderately severe
Very severe
Normal
History of skin disease
Stable
Worsened
Improved
Frequency of experiencing
3-6x per year
skin disease symptoms
1-2x per month
Constantly
1-2x per week
1-2x per year
1-2x per day
Pattern of skin symptoms
Chronic
Episodic
Seasonal
Acute
Other

40

n (%)
109 (35.0)
85 (27.3)
54 (17.4)
49 (15.8)
46 (14.8)
44 (14.1)
384
209 (67.2)
188 (60.5)
186 (59.8)
124 (39.9)
122 (39.2)
112 (36.0)
116 (37.3)
93 (29.9)
88 (28.3)
69 (22.2)
115 (37.0)
40 (12.9)
141 (45.3)
96 (30.8)
50 (16.1)
23 (7.4)
1 (0.3)
140 (45.0)
98 (31.5)
73 (23.5)
61 (19.6)
61 (19.6)
58 (18.6)
50 (16.1)
42 (13.5)
29 (9.3)
110 (35.4)
65 (20.9)
82 (26.4)
46 (14.8)
8 (2.6)
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Table 3 Potentially Traumatic Events Statistics
Happened
to me

Natural disaster (e.g., flood, tornado)
Fire or explosion
Transportation accident (e.g., car accident,
boat accident, train wreck, plane crash)
Serious accident at work, home, or during
recreational activity
Exposure to toxic substance (e.g., dangerous
chemicals, radiation)
Physical assault (e.g., being attacked, hit,
slapped, kicked, beaten up)
Assault with a weapon (e.g., being shot,
stabbed, threatened with a knife, gun, bomb)
Sexual assault (rape, attempted rape, made
to perform any type of sexual act through
force or threat of harm)
Other unwanted or uncomfortable sexual
experience
Combat or exposure to a war-zone (in the
military or as a civilian)
Captivity (e.g., being kidnapped, abducted,
held hostage, prisoner of war)
Life-threatening illness or injury
Severe human suffering
Sudden violent death (e.g., homicide,
suicide)
Sudden accidental death
Serious injury, harm, or death you caused to
someone else
Any other very stressful event or experience
% of individuals with PTE
Total # of PTEs M (SD)
Total # of PTEs Median
Total # of PTEs Mode
Range of PTEs
Note: PTE = Potentially Traumatic Event

n (%)
84 (27.0)
25 (8.0)
123 (39.5)

Witnessed
or Learned
about it
n (%)
139 (44.7)
129 (41.5)
148 (47.6)

Part of
my Job
n (%)
23 (7.4)
22 (7.1)
24 (7.7)

Not sure
or Does
not apply
n (%)
103 (33.1)
155 (49.8)
70 (22.5)

38 (12.2)

107 (34.4)

24 (7.7)

162 (52.1)

24 (7.7)

82 (26.4)

32 (10.3)

195 (62.7)

92 (29.6)

127 (40.8)

24 (7.7)

114 (36.7)

28 (9.0)

110 (35.4)

17 (5.5)

175 (56.3)

69 (22.2)

109 (35.0)

18 (5.8)

142 (45.7)

96 (30.9)

95 (30.5)

19 (6.1)

138 (44.4)

16 (5.1)

74 (23.8)

29 (9.3)

207 (66.6)

18 (5.8)

59 (19.0)

19 (6.1)

221 (71.1)

46 (14.8)
32 (10.3)
17 (5.5)

145 (46.6)
114 (36.7)
121 (38.9)

20 (6.4)
22 (7.1)
27 (8.7)

124 (39.9)
158 (50.8)
158 (50.8)

14 (4.5)
20 (6.4)

124 (39.9)
66 (21.2)

21 (6.8)
23 (7.4)

163 (52.4)
219 (70.4)

108 (34.7)
77.5 (241)
2.7 (2.7)
2
0
17

110 (35.4)
85.9 (267)
6.0 (4.7)
5
0
17

22 (7.1)
28.9 (90)
1.2 (2.5)
0
0
13

119 (38.3)
89.1 (277)
8.4 (5.4)
9
0
17
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Table 4 Pearson Correlations Between Study Variables
1
2
3
4
5
6
7
—
1. Skin Severity
—
2. PSS Total
.257
—
3. PCL Total
.435
.644
—
4. PCL Cluster B
.420
.560
.951
—
5. PCL Cluster C
.389
.592
.870
.850
—
6. PCL Cluster D
.402
.677
.972
.889
.811
—
7. PCL Cluster E
.428
.582
.947
.848
.752
.899
5.74
Mean
18.9
30.7
7.4
3.3
10.9
9.2
2.299
SD
6.6
22.0
6.1
2.5
8.0
6.5
0-10
Observed Range
0-34
0-80
0-20
0-8
0-28
0-24
0-10
Possible Range
0-34
0-80
0-20
0-8
0-28
0-24
Note: All correlations are significant at the p < .01 level (two-tailed); PCL = PTSD
Checklist for DSM-5; PSS = Perceived Stress Scale; Cluster B = intrusion cluster;
Cluster C = avoidance cluster; Cluster D = negative alterations in cognitions and mood
cluster; Cluster E = alterations in arousal and reactivity cluster
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Appendix A

Skin Disease Characteristics
Many of these questions ask about skin (dermatology) conditions or problems that you may have
experienced in the past year. For example: rosacea, acne, psoriasis, urticaria, vitiligo, alopecia,
eczema, hyperhidrosis.
1. What skin conditions or problems are you currently experiencing (within the past 4
weeks)?
2. What skin conditions or problems have you experienced in the past year (in addition to
those described in #1)?
3. In the last 12 months, have you seen a medical provider (physician, nurse, dermatologist)
for a skin-related problem?
4. Which condition or skin related symptoms currently bother you the most?
5. How would you rate the severity of your skin condition(s) on a scale 0 – 10 (0=normal,
10 is very severe)? _____
6. At what age did your skin condition symptoms first begin (e.g., childhood, 1 year ago)?
_________
7. Since you first experienced skin symptoms, your symptoms have been…
 Stable
 Worsened
 Improved
8. Overall, how often do you experience symptoms of your skin condition?
 Rarely
 1-2x per year
 3-6x per year
 1-2x per month
 1-2x per week
 1-2x each day
 Constantly
9. Please check the symptoms experienced in the past year or that you are currently
experiencing (i.e., within the past 4 weeks):
Current Past Year Symptom
Itching
Redness
Sores
Bleeding
Pain
Color changes
Rash/Hives
Outbreak
Dryness/Peeling
Sweating
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Burning/Stinging
Other
10. Areas of the body affected by skin problems/condition (check):
Current Past Year Area
Face
Neck
Scalp/Hair
Arms/Hands
Legs/Feet
Torso/Back
Groin
Other _________
11. How many times have you seen a medical provider for skin-related concerns in the past
year?
 None
 One time
 2-3
 4-6
 7-12
 13+
12. How many days have you missed from work/school/leisure activities because of your
symptoms in the past year? ______
13. What treatments have you received for your skin condition(s)?
 Oral medication
▪ Specify: type-strength-frequency
 Topical medication
▪ Specify: type-strength-frequency
 Botox/Injections
▪ Specify purpose – how many times
 Surgery
▪ Specify – purpose – how many times
 Over the counter topical creams/medications
▪ Type
 Other
▪ Describe:
14. If YES to 13: Thinking about the past month, on average how would you rate your ability
to follow through with treatment instructions for your skin symptoms?
 0 Very poor
 1 Poor
 2 Fair
 3 Good
 4 Very Good
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 5 Excellent
15. In the past month, did you miss ANY appointments with your doctors?
_____ Yes _____ No
16. About how many doctor appointments did you miss in the past month? _______ Past
year? _______
17. Weight:
18. Height:
19. Have you had any of these health problems in the past or currently (check all that apply)?
 Arthritis/rheumatism
 Allergies
 Asthma
 Frequent or severe headaches
 Migraine
 Seasonal allergies
 Heart attack
 High blood pressure
 Diabetes
 HIV/AIDS
 Ulcers
 Hives
 Back or Neck problems
 Other chronic pain
 Stroke
 Obesity
 Heart disease
 Chronic lung disease (other than asthma)
 Kidney problems
 Epilepsy/seizures
 Skin Cancer
 Other cancer
How would you describe the pattern of these skin symptoms since you were first
diagnosed?
Acute (onset suddenly)
Chronic
Episodic
Seasonal (occurs regularly, but are associated with seasonal patterns such as winter/cold, heat,
certain things blooming, etc.)
Other
When was your last medical appointment for skin-related problems?
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When is your next medical appointment for skin-related problems?
What type of provider do you see for your dermatology/skin disease?
Dermatologist
General physician
Cosmetologist
Other, please specify:
How visible are your skin symptoms to other people?
Not at all visible
Slightly visible
Moderately visible
Very visible
How concerned are you that other people would see or notice your dermatology/skin
symptoms?
Not at all
Slightly
Somewhat
Moderately
Extremely
Do you try to cover or hide your skin symptoms (e.g., clothes, grow a beard, make up,
bandages, etc.)? Yes/no
What do you do?
How concerned are you to be intimate or engage in sexual activities with someone due to
your dermatology/skin symptoms?
Not at all
Slightly
Somewhat
Moderately
Extremely

46

PTSD & SKIN DISEASE SEVERITY

47
Appendix B

Life Events Checklist for DSM-5
Listed below are a number of difficult or stressful things that sometimes happen to people. For
each event check one or more of the boxes to the right to indicate that: (a) it happened to you
personally; (b) you witnessed it happen to someone else; (c) you learned about it happening to a
close family member or close friend; (d) you were exposed to it as part of your job (for example,
paramedic, police, military, or other first responder); (e) you’re not sure if it fits; or (f) it doesn’t
apply to you. Be sure to consider your entire life (growing up as well as adulthood) as you go
through the list of events.
Event
1. Natural disaster (for
example, flood,
hurricane, tornado,
earthquake)
2. Fire or explosion
3. Transportation accident
(for example, car
accident, boat accident,
train wreck, plane crash)
4. Serious accident at work,
home, or during
recreational activity
5. Exposure to toxic
substance (for example,
dangerous chemicals,
radiation)
6. Physical assault (for
example, being attacked,
hit, slapped, kicked,
beaten up)
7. Assault with a weapon
(for example, being shot,
stabbed, threatened with a
knife, gun, bomb)
8. Sexual assault (rape,
attempted rape, made to
perform any type of
sexual act through force
or threat of harm)

Happened Witnessed
to me
it

Learned
about it

Part
of my
job

Not
sure

Doesn’t
apply
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9. Other unwanted or
uncomfortable sexual
experience
10. Combat or exposure to a
war-zone (in the military
or as a civilian)
11. Captivity (for example,
being kidnapped,
abducted, held hostage,
prisoner of war)
12. Life-threatening illness or
injury
13. Severe human suffering
14. Sudden violent death (for
example, homicide,
suicide)
15. Sudden accidental death
16. Serious injury, harm, or
death you caused to
someone else
17. Any other very stressful
event or experience
PART 2:
A. If you check anything for #17 in PART 1, briefly identify the event you were thinking of:
________________________________________________________________________
B. If you have experienced more than one of the events in PART 1, think about the event
you consider the worst event, which for this questionnaire means the event that currently
bothers you the most. If you have experienced only one of the events in PART 1, use that
one as the worst event. Please answer the following questions about the worst event
(check all options that apply):
1. Briefly describe the worst event (for example, what happened, who was involved, etc.).
________________________________________________________________________
________________________________________________________________________
2. How long ago did it happen? _______________________ (please estimate if not sure)
3. How did you experience it?
_____ It happened to me directly
_____ I witnessed it
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_____ I learned about it happening to a close family member or close friend
_____ I was repeatedly exposed to details about it as part of my job (for example,
paramedic, police, military, or other first responder)
_____ Other, please describe:
4. Was someone’s life in danger?
_____ Yes, my life
_____ Yes, someone else’s life
_____ No
5. Was someone seriously injured or killed?
_____ Yes, I was seriously injured
_____ Yes, someone else was seriously injured or killed
_____ No
6. Did it involve sexual violence? _____Yes ____No
7. If the event involved the death of a close family member or close friend, was it due to
some kind of accident or violence, or was it due to natural causes?
_____ Accident or violence
_____ Natural causes
_____ Not applicable (The event did not include the death of a close family member or
close friend)
8. How many times altogether have you experienced a similar event as stressful or nearly as
stressful as the worst event?
_____ Just once
_____ More than once (please specify or estimate the total # of times you have had
this experience _____)
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Appendix C

PTSD Checklist for DSM-5
Below is a list of problems that people sometimes have in response to a very stressful
experience. Keeping your worst event in mind, please read each problem carefully and then
circle one of the numbers to the right to indicate how much you have been bothered by that
problem in the past month.
In the past month, how much were you
Not A little
bothered by:
at all
bit
1. Repeated, disturbing, and unwanted
0
1
memories of the stressful experience?
2. Repeated, disturbing dreams of the
0
1
stressful experience?
3. Suddenly feeling or acting as if the
stressful experience were actually
0
1
happening again (as if you were
actually back there reliving it)?
4. Feeling very upset when something
reminded you of the stressful
0
1
experience?
5. Having strong physical reactions when
something reminded you of the
stressful experience (for example, heart
0
1
pounding, trouble breathing,
sweating)?
6. Avoiding memories, thoughts, or
feelings related to the stressful
0
1
experience?
7. Avoiding external reminders of the
stressful experience (for example,
0
1
people, places, conversations,
activities, objects, or situations)?
8. Trouble remembering important parts
0
1
of the stressful experience?
9. Having strong negative beliefs about
yourself, other people, or the world (for
example, having thoughts such as: I am
0
1
bad, there is something seriously wrong
with me, no one can be trusted, the
world is completely dangerous)?
10. Blaming yourself or someone else for
the stressful experience or what
0
1
happened after it?
11. Having strong negative feelings such as
0
1
fear, horror, anger, guilt, or shame?

Moderately

Quite Extremely
a bit

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4

2

3

4
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12. Loss of interest in activities that you
used to enjoy?
13. Feeling distant or cut off from other
people?
14. Trouble experiencing positive feelings
(for example, being unable to feel
happiness or have loving feelings for
people close to you)?
15. Irritable behavior, angry outbursts, or
acting aggressively?
16. Taking too many risks or doing things
that could cause you harm?
17. Being “superalert” or watchful or on
guard?
18. Feeling jumpy or easily startled?
19. Having difficulty concentrating?
20. Trouble falling or staying asleep?
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Appendix D

Perceived Stress Scale
The questions in this scale ask you about your feelings and thoughts during the last month. In
each case, you will be asked to indicate by circling how often you felt or thought a certain way.
For each question choose from the following alternatives:
0 - never 1 - almost never 2 - sometimes 3 - fairly often 4 - very often
________ l. In the last month, how often have you been upset because of something that
happened unexpectedly?
________ 2. In the last month, how often have you felt that you were unable to control the
important things in your life?
________ 3. In the last month, how often have you felt nervous and stressed?
________ 4. In the last month, how often have you felt confident about your ability to handle
your personal problems?
________ 5. In the last month, how often have you felt that things were going your way?
________ 6. In the last month, how often have you found that you could not cope with all the
things that you had to do?
________ 7. In the last month, how often have you been able to control irritations in your life?
________ 8. In the last month, how often have you felt that you were on top of things?
________ 9. In the last month, how often have you been angered because of things that happened
that were outside of your control?
________ 10. In the last month, how often have you felt difficulties were piling up so high that
you could not overcome them?

